CD36 is an integral transmembrane glycoprotein detected in various tissues and has a role in high-affinity uptake of long-chain fatty acids.[59] Overexpressed CD36 expression predicts poor prognosis in ccRCC patients.[60] LncRNA SNHG16 promotes ccRCC cell migration and invasion through suppression of CDKN1A.[61] The lncRNA DMDRMR assists IGF2BP3 in stabilizing target genes as a cofactor in an m6A-dependent manner, thus exerting essential oncogenic roles in ccRCC.[62] A high level of F2RL3 was observed to correlate with aggressive features and poor survival in ccRCC.[63]. Here, CD36 is linked to nonpapillary renal cell carcinoma.